Financial News
Press Releases about Summit Therapeu ADR
![](https://mms.businesswire.com/media/20230809529387/en/1691422/5/Summit-logo-RGB.jpg)
![](https://mms.businesswire.com/media/20230802984278/en/1691422/5/Summit-logo-RGB.jpg)
![](https://mms.businesswire.com/media/20230604005026/en/1691422/5/Summit-logo-RGB.jpg)
![](https://mms.businesswire.com/media/20230601005388/en/1691422/5/Summit-logo-RGB.jpg)
Ivonescimab Updated Data to be Featured at ASCO 2023
June 01, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230511005349/en/1691422/5/Summit-logo-RGB.jpg)
![](https://mms.businesswire.com/media/20230509005525/en/1691422/5/Summit-logo-RGB.jpg)
![](https://mms.businesswire.com/media/20230502005528/en/1691422/5/Summit-logo-RGB.jpg)
![](https://mms.businesswire.com/media/20230321005458/en/827144/22/Schall-Firm-Logo-640x360.jpg)
![](https://mms.businesswire.com/media/20230320005674/en/827144/22/Schall-Firm-Logo-640x360.jpg)
![](https://mms.businesswire.com/media/20230309005355/en/1691422/5/Summit-logo-RGB.jpg)
![](https://mms.businesswire.com/media/20230303005082/en/1691422/5/Summit-logo-RGB.jpg)
![](https://mms.businesswire.com/media/20230223005463/en/1691422/5/Summit-logo-RGB.jpg)
Summit Therapeutics’ Rights Offering Nearing Expiration Date
February 23, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230130005214/en/1691422/5/Summit-logo-RGB.jpg)
![](https://mms.businesswire.com/media/20230120005080/en/1691416/5/Summit-logo-RGB.jpg)
![](https://mms.businesswire.com/media/20230105005453/en/1677854/5/Summit-logo-RGB.jpg)
![](https://mms.businesswire.com/media/20211228005186/en/827144/5/Schall-Firm-Logo-640x360.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.